Literature DB >> 23592172

Examining the accuracy and clinical usefulness of intraoperative frozen section analysis in the management of pancreatic lesions.

Daniel W Nelson1, Terin H Blanchard, Marlin W Causey, Joseph F Homann, Tommy A Brown.   

Abstract

BACKGROUND: Intraoperative frozen section analysis is often performed in the surgical management of pancreatic lesions. This test is used to obtain histologic diagnosis, to assess resectability because of unanticipated locoregional spread, and to ensure negative margins after resection. We sought to define the accuracy and clinical usefulness of intraoperative frozen section analysis in patients with pancreatic lesions and to determine the impact on long-term outcomes.
METHODS: A retrospective database review was performed for all patients who underwent pancreatic resection at our institution from 2002 to 2011. Patient demographics, indications for frozen section analysis, final pathology, and long-term outcomes were analyzed. Five-year survival was compared using the Kaplan-Meier method.
RESULTS: Sixty-eight patients were identified (mean age 65 ± 14 years, 52% female). Malignancy was identified on final pathology in 38 (56%) patients. Intraoperative frozen section analysis was performed in 59 (87%) patients. Frozen section analysis was performed for histologic diagnosis in 6 (10%) cases, to determine resectability in 15 (25%) cases, and to evaluate margin status in 58 (98%) cases. Frozen section analysis for histologic diagnosis was associated with a sensitivity of 80%, a specificity of 100%, a positive predictive value of 100%, and a negative predictive value of 50% with an overall accuracy of 83%. Frozen section analysis for the determination of resectability was associated with a sensitivity of 38%, specificity of 100%, a positive predictive value of 100%, and a negative predictive value of 58% with an overall accuracy of 66%. Intraoperative frozen section analysis for the determination of the final margin status was associated with a sensitivity of 33%, specificity of 100%, a positive predictive value of 100%, and a negative predictive value of 97% with an overall accuracy of 97%. There were no false-positive results on frozen section analysis. Errors on frozen section analysis interpretation did not negatively impact survival outcomes (mean survival = 2.2 years in those with concordant frozen section analysis vs 1.7 years in those with discordant frozen section analysis, P = .69).
CONCLUSIONS: Although intraoperative frozen section analysis is helpful for ensuring negative final margins, its usefulness for obtaining histologic diagnosis and determining resectability is limited by low negative predictive potential. These results highlight the importance of preoperative staging and intraoperative surgical judgment for questionable resectable disease. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23592172     DOI: 10.1016/j.amjsurg.2013.01.015

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

1.  Indocyanine green loaded hyaluronan-derived nanoparticles for fluorescence-enhanced surgical imaging of pancreatic cancer.

Authors:  Bowen Qi; Ayrianne J Crawford; Nicholas E Wojtynek; Megan B Holmes; Joshua J Souchek; Graca Almeida-Porada; Quan P Ly; Samuel M Cohen; Michael A Hollingsworth; Aaron M Mohs
Journal:  Nanomedicine       Date:  2018-01-09       Impact factor: 5.307

2.  Can laboratory x-ray virtual histology provide intraoperative 3D tumor resection margin assessment?

Authors:  William Twengström; Carlos F Moro; Jenny Romell; Jakob C Larsson; Ernesto Sparrelid; Mikael Björnstedt; Hans M Hertz
Journal:  J Med Imaging (Bellingham)       Date:  2022-02-07

Review 3.  Advances in Diagnostic and Intraoperative Molecular Imaging of Pancreatic Cancer.

Authors:  Willemieke S Tummers; Juergen K Willmann; Bert A Bonsing; Alexander L Vahrmeijer; Sanjiv S Gambhir; Rutger-Jan Swijnenburg
Journal:  Pancreas       Date:  2018-07       Impact factor: 3.327

Review 4.  Current and future intraoperative imaging strategies to increase radical resection rates in pancreatic cancer surgery.

Authors:  Henricus J M Handgraaf; Martin C Boonstra; Arian R Van Erkel; Bert A Bonsing; Hein Putter; Cornelis J H Van De Velde; Alexander L Vahrmeijer; J Sven D Mieog
Journal:  Biomed Res Int       Date:  2014-07-15       Impact factor: 3.411

5.  Validation of full-field optical coherence tomography in distinguishing malignant and benign tissue in resected pancreatic cancer specimens.

Authors:  Labrinus van Manen; Paulien L Stegehuis; Arantza Fariña-Sarasqueta; Lorraine M de Haan; Jeroen Eggermont; Bert A Bonsing; Hans Morreau; Boudewijn P F Lelieveldt; Cornelis J H van de Velde; Alexander L Vahrmeijer; Jouke Dijkstra; J Sven D Mieog
Journal:  PLoS One       Date:  2017-04-17       Impact factor: 3.240

6.  Impact of intraoperative margin clearance on survival following pancreatoduodenectomy for pancreatic cancer: a systematic review and meta-analysis.

Authors:  Emrullah Birgin; Erik Rasbach; Patrick Téoule; Felix Rückert; Christoph Reissfelder; Nuh N Rahbari
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

7.  Rapid diagnosis and tumor margin assessment during pancreatic cancer surgery with the MasSpec Pen technology.

Authors:  Mary E King; Jialing Zhang; John Q Lin; Kyana Y Garza; Rachel J DeHoog; Clara L Feider; Alena Bensussan; Marta Sans; Anna Krieger; Sunil Badal; Michael F Keating; Spencer Woody; Sadhna Dhingra; Wendong Yu; Christopher Pirko; Kirtan A Brahmbhatt; George Van Buren; William E Fisher; James Suliburk; Livia S Eberlin
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

8.  Factors predicting survival in patients with locally advanced pancreatic cancer undergoing pancreatectomy with arterial resection.

Authors:  Niccolò Napoli; Emanuele Kauffmann; Concetta Cacace; Francesca Menonna; Davide Caramella; Carla Cappelli; Daniela Campani; Andrea Cacciato Insilla; Enrico Vasile; Caterina Vivaldi; Lorenzo Fornaro; Gabriella Amorese; Fabio Vistoli; Ugo Boggi
Journal:  Updates Surg       Date:  2020-09-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.